Biblio
.
Evaluation of elafin as a prognostic biomarker in acute graft-versus-host disease. Transplant Cell Ther. 2021.
A day 14 endpoint for acute GVHD clinical trials. Transplant Cell Ther. 2024.
COVID-19 Outcomes in Children, Adolescents and Young Adults with Cancer. Int J Cancer. 2022.
.